ʻO ka hoʻopiʻi no ka US $ 7.7 biliona ʻaʻole ia he pono kālā hou akā he ʻāpana ia o kā ACT-Accelerator's budget 2021 āpau, e pono ai i loko o nā mahina ʻehā e hiki mai ana e hakakā me nā ʻano COVID.
ʻO ka hoʻāʻo kūpono ʻole a me nā helu hoʻohaʻahaʻa haʻahaʻa e hoʻonui ana i ka lawe ʻana o ka maʻi a me nā ʻōnaehana olakino kūloko.
Ke waiho nei ke kūlana i kēia manawa i ka honua āpau i nā ʻano hou.

Ke ʻike nei nā ʻāina he nui i nā nalu hou o nā maʻi - a ʻoiai he nui nā ʻāina loaʻa kālā kiʻekiʻe a me kekahi mau ʻāina loaʻa waena kiʻekiʻe i hoʻokō i nā lāʻau ākea ākea, hoʻokau i nā ʻōnaehana hoʻokolohua ikaika aʻe, a hoʻomāhuahua hou ʻia nā lapaʻau - nui haʻahaʻa a me waena. -o nā ʻāina e hakakā nei e kiʻi i kēia mau pono pono no ka nele o ke kālā a me nā lako. Ua hoʻolaha ka World Health Organisation (WHO) i ka hoʻopukapuka ʻana i ka ACT-Accelerator e hoʻolako i nā pono hana i kēlā me kēia, ma nā wahi āpau, e pōmaikaʻi i nā ʻāina āpau ma o ka pane o ka honua a puni a me ka pane like.

ʻO ke komo i ka COVID-19 Tools Accelerator (ACT-Accelerator) kahi hui lōkahi o nā hui e hoʻomohala a hoʻoili i nā diagnostics, nā lāʻau lapaʻau a me nā lāʻau āpau e pono ai e hoʻopau i ka wā nui o ka maʻi ahulau. Ua hoʻokumu ʻia kēia pilina ma ka hoʻomaka ʻana o ka maʻi ahulau i ka pane ʻana i kahi kāhea mai nā alakaʻi G20 a ua hoʻokumu ʻia i ʻApelila 2020 ma kahi hanana i mālama ʻia e ka Luna Hoʻokele Nui o ka World Health Organization, ka Pelekikena o Palani, ka Pelekikena o ka ʻO ke Komisina ʻEulopa, a me ka Bill & Melinda Gates Foundation. ʻO ke kālā koʻikoʻi no ka hoʻāʻo ʻana mai ka hoʻoliʻiliʻi mua ʻole o nā mea hāʻawi, e like me nā ʻāina, nā ʻāpana pilikino, nā philanthropists, a me nā hoa multilateral.

ʻOiai 4 ʻano ʻē o ka hopohopo ke hoʻomalu nei i ka maʻi epidemiology, aia ka makaʻu i ka mea hou, a ʻoi aku paha ka weliweli, e kū mai nā ʻano ʻano hopohopo.

Me nā loaʻa lanakila paʻakikī o 3 mau mahina i ka makaʻu, ua kau ka ACT-Accelerator i kahi US $7.7 biliona hoʻopiʻi, ka Rapid ACT-Accelerator Delta Response (RADAR), i ka wikiwiki:

Hoʻohālikelike i ka hoʻāʻo ʻana: ʻO US $ 2.4 biliona e kau i nā ʻāina haʻahaʻa a haʻahaʻa ma waena i loaʻa ma ke ala i kahi hoʻonui he ʻumi pā o ka hoʻāʻo COVID-19 a hōʻoia i nā ʻāina āpau e kū i nā pae hoʻokolokolo maikaʻi. E hoʻomaikaʻi nui kēia i ka ʻike kūloko a me ka honua no ka hoʻololi ʻana i ka maʻi epidemiology a me nā ʻano ʻē aʻe e kū nei i ka hopohopo, e hoʻomaopopo i ka noi kūpono o ke olakino lehulehu a me nā hana kaiāulu a haki nā kaulahao o ka lawe ʻana.
Mālama i nā hana R&D e noho i mua o ka maʻi. ʻO US $ 1 biliona no ka R&D e hoʻomau nei, e hiki ai ke hana hou i ka mākeke a me ka hana ʻana, kōkua ʻenehana a me ka hanauna koi e hōʻoia i ka maikaʻi o nā hoʻokolohua, nā mālama ʻana a me nā lāʻau āpau e kūʻē i ka Delta variant a me nā ʻano ʻē aʻe e kū mai ana, a hiki ke maʻalahi a maʻalahi hoʻi kahi e pono ai.
Pono e mālama i ka oxygen nui e mālama i nā ola: ʻO US $ 1.2 biliona e hoʻoponopono wikiwiki ai i ka oxygen e pono ai e mālama i ka poʻe maʻi nui a kāohi i nā piʻi make exponential i hoʻokumu ʻia e ka Delta variant.
Rollout o nā pono hana: ʻO US $ 1.4 biliona e kōkua i nā ʻāina e ʻike a kamaʻilio i nā ʻōmole kī nui no ka hoʻokomo pono ʻana a me ka hoʻohana ʻana i nā mea hana COVID-19 āpau. E like me ka lako ʻana o nā lāʻau āpau COVID-19 i nā mahina e hiki mai ana, pono ka waihona kālā maʻalahi e kōkua e hoʻopihapiha i nā wahi o ka pae honua.
Palekana i nā limahana olakino mua: US $ 1.7 biliona e hoʻolako i ʻelua miliona mau limahana olakino pono me ka PPE maʻamau e mālama pono iā lākou i ka wā e mālama ana lākou i ka poʻe maʻi, pale i ka hāʻule o nā ʻōnaehana olakino kahi i hana ʻole ʻia ai ka limahana olakino, a pale i ka hoʻolaha hou ʻana o COVID-19.

Ma waho aʻe o ka hoʻopiʻi US $ 7.7 biliona, aia kahi manawa kūpono e mālama ai i ka lako o nā lāʻau āpau ma o ka hoʻohana ʻana i nā koho i ka hāhā o ka makahiki 2021 no 760 miliona mau lāʻau o ka lāʻau lapaʻau i loaʻa ma waenakonu o 2022 ma ʻō aku o nā lāʻau i hāʻawi ʻia a COVAX e hāʻawi ai. a hiki i ka hopena o Q1 2022. ʻO nā ʻōlelo hoʻohiki e mālama i kēia mau koho vaccine i ka hapahā hope o ka makahiki no ka lawe ʻana ma waenakonu o 2022 hiki ke hana ʻia iā Gavi / COVAX, ma ke ʻano he ʻāpana o nā kikowaena ʻoihana ACT-A.

Hāʻawi kahi waihona i 760 miliona mau lāʻau o ka lāʻau lapaʻau ma o ka hoʻohana ʻana i nā koho i ka hapaha hope o kēia makahiki e hōʻoia i ka loaʻa mau o ka lako e hiki ai ke lawe i nā 2022 e koi ana i ke kapikala contingent. ʻO ke lawe ʻana i kēia 760 miliona mau lāʻau e uku i kahi US $ 3.8 biliona hou.

Ua haʻi ʻo Dr. Tedros Adhanom Ghebreyesus, ka Luna Hoʻokele o WHO: "He $ 7.7 biliona ka pono e pono ai e hoʻopukapuka kālā i ka hana a ka ACT-Accelerator e hoʻoponopono ai i ka piʻina Delta a hoʻokau i ka honua i ke ala e pau ai ke ahulau. ʻO kēia hoʻopukapuka kahi ʻāpana liʻiliʻi o ka nui a ke aupuni e hoʻolilo nei e hana pū me COVID-19 a lilo i ʻano ethical, economic and epidemiological sense. Inā ʻaʻole loaʻa kēia kālā i kēia manawa e kāpae i ka lawe ʻana o Delta i nā ʻāina nāwaliwali loa, e uku nō mākou āpau i nā hopena ma hope o ka makahiki.

Ua ʻōlelo ʻo Carl Bildt, ka ʻelele kūikawā o WHO i ka ACT-Accelerator: 19 kumu. ʻO ka puka aniani no ka hana i kēia manawa. "

Ua hoʻolaha aku nei ka ACT-Accelerator i kāna Hōʻike Hoʻohou Q2 2021, e hāʻawi nei i kahi nānā o ka holomua i hana ʻia i ka lawe ʻana i nā mea hana ola COVID-19 i nā ʻāina a puni ka honua, a hōʻike i nā hana i hana ʻia e hiki ai i nā ʻōnaehana olakino ke loaʻa a hoʻonui piha i ka hoʻohana ʻana o COVID-19 countermeasures, i ka wā o ka ʻApelila-i-Iune 2021 manawa. Hōʻike ia i ka hopena o nā hoʻopukapuka i hana ʻia i ka ACT-Accelerator i hopena i nā hopena a me ka hopena i ka hakakā ʻana me COVID-19.

ʻO ka hoʻonui ʻana i ka haʻiʻōlelo a me nā hana hou i ka mea i koi ʻia e hoʻokō i ke kaulike i ke kaua kūʻē ʻana i ka maʻi ahulau. I loko o 15 mau mahina wale nō, ma ʻAukake 9, 2021, ua piʻi aʻe ka poʻe hāʻawi kālā a hāʻawi iā US $ 17.8 biliona o ko ACT-Accelerator's US $ 38.1 biliona pono kālā. ʻO kēia manawaleʻa mua ʻole i hoʻokau i ka wikiwiki a me ka hana i hoʻohui ʻia i ka mōʻaukala e hoʻomohala i nā pono hana e pale ai i ka palekana olakino ākea, a e hāʻawi i ka hopena ma kahi e pono ai.

Nā mea i loaʻa ma waena o nā kia ACT-Accelerator me:

ʻO Diagostics kia, hui pū ʻia e FIND a me ka Global Fund, e hana pū nei me UNITAID, UNICEF, WHO a ʻoi aku ma luna o 30 mau hoa olakino honua e hoʻonui i ke komo kaulike ʻana i nā ʻenehana diagnostical COVID-19:

Ma mua o 84 miliona mau mole a me nā antigen wikiwiki diagnostic ho'āʻo (RDTs) i loaʻa ma o ka Diagnostics Consortium
Ua hāʻawi ʻia ka hana ʻana i nā ʻāpana e hoʻoulu ʻia ma o ka lawe ʻenehana
Kākoʻo ʻia nā ʻāina he 70 e hoʻonui i nā hanana ʻōnaehana a hoʻonui i ka hoʻāʻo ʻana.

Pou kiaola, hui pū ʻia e Wellcome, Unitaid, kākoʻo ʻia e WHO, UNICEF a me ka Fund Global i:

Loaʻa iā US $ 37 miliona mau waiwai o nā mālama e like me 3 miliona o ka dexamethasone, a me US $ 316 miliona o nā lako oxygen.
Kākoʻo ʻike ʻia o ka hoʻōla hoʻōla ola mua loa no COVID-19 - dexamethasone - a hāʻawi i ke alakaʻi ākea e pili ana i ka hoʻohana.
Ua hoʻoneʻe ʻia kahi limahana o COVID-19 Oxygen Emergency e nānā a kamaʻilio i nā piʻi o COVID-19 i ke koi e ʻoki i nā make hiki ke pale ʻia. Ua ʻāpana pū kekahi kia i ka ʻaelike no nā mea hoʻolako i ka oxygen nui ʻoi loa o ka honua - Air Liquide a me Linde - e laulima pū me nā hoa ʻo ACT-Accelerator e hoʻonui i ke komo ʻana i ka oxygen ma nā ʻāina haʻahaʻa a haʻahaʻa o waena. ʻO ke koi ākea no ka oxygen lapaʻau i kēia manawa ʻoi aku ma mua o ke kakini mau manawa i ʻoi aku ma mua o ka maʻi ahulau.
Mai ka hoʻomaka o ka maʻi ahulau a hiki i Iulai 1, 2021, ma kahi o US $ 97 miliona o nā lako oxygen (2.7 miliona mau mea) i hoʻouna ʻia i nā ʻāina.
Hoʻohui ʻia, i ka hapahā hope loa, ua hāʻawi ʻia he $ 219 miliona i nā ʻāina no ke kūʻai ʻana i nā lako o ka oxygen, e like me nā concentrator oxygen a me nā mea kanu oxygen lehulehu, ma o ka Global Fund COVID-19 Response Mechanism.

ʻO COVAX, ka pou ʻOihana, hui pū ʻia e ka Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, ka Vaccine Alliance a me ka World Health Organization (WHO) - ke hana pū nei me UNICEF ma ke ʻano he hoa hoʻokō nui, a me nā mea hana lāʻau lapaʻau, nā hui kaiāulu civila, a ka World Bank he:

Hōʻeleu i ka noiʻi a me ka hoʻomohala ʻana o kahi kōpaki o 11 mau moho lāʻau kūpaka ma nā ʻenehana ʻehā.
Hoʻouna ʻia i ka huina o 186.2 miliona mau lāʻau lapaʻau i 138 mau ʻāina a me nā hoʻokele waiwai (a hiki i 5 ʻAukake 2021). I kēia mau mea, ua hoʻouna ʻia he 137.5 miliona mau kaha ma nā ʻāina a me nā hoʻokele waiwai he 84 AMC. Manaʻo ʻia e loaʻa ana nā huina o 1.9 biliona dosis no ka lawe ma ka hopena o 2021. No kēia mau mea, manaʻo ʻia nā mea komo o ka AMC e loaʻa ma kahi o 1.5 biliona lāʻau, e like me nā mea i hāʻawi ʻia, e like me ka 23% ka nui o ka lehulehu (koe aku ʻo India) .
Kukulu ʻia kahi hana hana hana e hoʻomaopopo a hoʻoholo i nā pilikia hana e kāohi ana i ke komo kaulike ʻana i nā lāʻau āpau ma o COVAX. Ke kamaʻilio wikiwiki nei ka Taskforce i nā pilikia a me nā ʻōmole pōkole a me ka hana pū ʻana me kahi consortium ma ʻApelika Hema e hoʻoili i ka ʻenehana a hoʻokumu i kahi keʻena hana lāʻau lapaʻau ma ka ʻāina, e hōʻoia ana i ka palekana olakino wā lōʻihi.

Hoʻohui Pūnaewele Ola, hui pū ʻia e ka Global Fund, ʻo WHO a me ka Bank Bank.

Ma ka hopena o ʻApelila, kūʻai aku ʻo PPE i ʻoi aku ka nui ma mua o US $ 500 miliona, mākaukau ka mākaukau ʻāina no ka hoʻouka ʻana o nā lāʻau āpau COVID-19 ma mua o 140 mau ʻāina (i hui pū ʻia e World Bank, GFF, Gavi, ka Global Fund, UNICEF a me WHO), a me nā mea hoʻopalapala i kākau ʻia. i 90% o nā ʻōnaehana olakino a me nā lawelawe ma o nā loiloi lāʻau pulse lāhui ma mua o 100 mau ʻāina.
ʻO nā ʻike pili i ka ʻāina i hopu ʻia ma nā bottlenecks a me nā luʻi e pili ana i nā ʻōnaehana olakino e hoʻomau ana i nā alakaʻi a me ka hoʻomaʻamaʻa honua ma nā wahi ʻōnaehana olakino koʻikoʻi.
Kōkua i ka hōʻemi ʻana i nā kumukūʻai PPE, a hiki i ka 90% hōʻemi kiʻekiʻe ma luna o nā mākaki lāʻau a me nā hanu N95 / FFP2. ʻO ka Global Fund, ma o ka COVID-19 Response Mechanism (C19RM), a me ka Global Financing Facility, ma o ka COVID-19 Essential Health Services, i hāʻawi ʻia i nā makana i nā ʻāina e kūʻai iā PPE, e hāʻawi i nā lāʻau a hoʻomaʻamaʻa i nā limahana olakino kaiāulu i ka huakaʻi lāʻau lapaʻau i hoʻoikaika i ka pane aupuni COVID-19.
ʻO ka waihona PPE i hoʻonohonoho mua ʻia e UNICEF ma nā hale ukana ma Copenhagen, Dubai, Panama a me Shanghai i loaʻa koke no ka lawe ʻana i nā ʻāina e pono ai, hiki ke loaʻa kālā.

He aha e lawe ʻia mai kēia ʻatikala:

This partnership was formed at the onset of the pandemic in response to a call from G20 leaders and was launched in April 2020 at an event co-hosted by the Director-General of the World Health Organization, the President of France, the President of the European Commission, and the Bill &.
7 billion appeal, there is an opportunity to reserve the supply of vaccines through exercising options in the fourth quarter of 2021 for 760 million doses of vaccine to be available in mid-2022 beyond the fully subsidized doses that COVAX will deliver up to the end of Q1 2022.
The Access to COVID-19 Tools Accelerator (ACT-Accelerator) is a global coalition of organizations developing and deploying the new diagnostics, treatments and vaccines needed to end the acute phase of the pandemic.